Search research articles
Contact Us
Filters
Showing results (51-60 of 63) with videos related to
Page
of 7
Sort By:
Gene Therapy
|
June 26, 2001
T cells engrafted with a recombinant anti-CD30 receptor target autologous CD30(+) cutaneous lymphoma cells
A Hombach, J M Muche, M Gerken, et al.
Cancer Research
|
May 1, 1997
Prevention of Epstein-Barr virus-induced human B-cell lymphoma in severe combined immunodeficient mice treated with CD3xCD19 bispecific antibodies, CD28 monospecific antibodies, and autologous T cells
H Bohlen, O Manzke, S Titzer, et al.
Annals of Internal Medicine
|
December 15, 1988
Fatal Hodgkin and non-Hodgkin lymphoma associated with persistent Epstein-Barr virus in four brothers
R Donhuijsen-Ant, H Abken, G Bornkamm, et al.
Gut
|
February 13, 2004
An interleukin 12 p40-IgG2b fusion protein abrogates T cell mediated inflammation: anti-inflammatory activity in Crohn's disease and experimental colitis in vivo
A Stallmach, T Marth, B Weiss, et al.
Gut
|
September 29, 2005
A recombinant anti-carcinoembryonic antigen immunoreceptor with combined CD3zeta-CD28 signalling targets T cells from colorectal cancer patients against their tumour cells
A Hombach, C Schlimper, E Sievers, et al.
The Journal of Investigative Dermatology
|
May 8, 1999
Specific lysis of melanoma cells by receptor grafted T cells is enhanced by anti-idiotypic monoclonal antibodies directed to the scFv domain of the receptor
U Reinhold, L Liu, H C Lüdtke-Handjery, et al.
Gene Therapy
|
January 23, 2009
Transfer of mRNA encoding recombinant immunoreceptors reprograms CD4+ and CD8+ T cells for use in the adoptive immunotherapy of cancer
K Birkholz, A Hombach, C Krug, et al.
Leukemia
|
May 3, 2002
CD4+CD7- leukemic T cells from patients with Sézary syndrome are protected from galectin-1-triggered T cell death
G Rappl, H Abken, J M Muche, et al.
International Journal of Cancer
|
August 30, 2000
An entirely humanized CD3 zeta-chain signaling receptor that directs peripheral blood t cells to specific lysis of carcinoembryonic antigen-positive tumor cells
A Hombach, C Schneider, D Sent, et al.
Der Pathologe
|
August 24, 2010
[Adoptive T-cell therapy of rhabdomyosarcoma]
K Simon-Keller, A Paschen, S Eichmüller, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 63) with videos related to
Sort By:
Page
of 7
Gene Therapy
|
June 26, 2001
T cells engrafted with a recombinant anti-CD30 receptor target autologous CD30(+) cutaneous lymphoma cells
A Hombach, J M Muche, M Gerken, et al.
Cancer Research
|
May 1, 1997
Prevention of Epstein-Barr virus-induced human B-cell lymphoma in severe combined immunodeficient mice treated with CD3xCD19 bispecific antibodies, CD28 monospecific antibodies, and autologous T cells
H Bohlen, O Manzke, S Titzer, et al.
Annals of Internal Medicine
|
December 15, 1988
Fatal Hodgkin and non-Hodgkin lymphoma associated with persistent Epstein-Barr virus in four brothers
R Donhuijsen-Ant, H Abken, G Bornkamm, et al.
Gut
|
February 13, 2004
An interleukin 12 p40-IgG2b fusion protein abrogates T cell mediated inflammation: anti-inflammatory activity in Crohn's disease and experimental colitis in vivo
A Stallmach, T Marth, B Weiss, et al.
Gut
|
September 29, 2005
A recombinant anti-carcinoembryonic antigen immunoreceptor with combined CD3zeta-CD28 signalling targets T cells from colorectal cancer patients against their tumour cells
A Hombach, C Schlimper, E Sievers, et al.
The Journal of Investigative Dermatology
|
May 8, 1999
Specific lysis of melanoma cells by receptor grafted T cells is enhanced by anti-idiotypic monoclonal antibodies directed to the scFv domain of the receptor
U Reinhold, L Liu, H C Lüdtke-Handjery, et al.
Gene Therapy
|
January 23, 2009
Transfer of mRNA encoding recombinant immunoreceptors reprograms CD4+ and CD8+ T cells for use in the adoptive immunotherapy of cancer
K Birkholz, A Hombach, C Krug, et al.
Leukemia
|
May 3, 2002
CD4+CD7- leukemic T cells from patients with Sézary syndrome are protected from galectin-1-triggered T cell death
G Rappl, H Abken, J M Muche, et al.
International Journal of Cancer
|
August 30, 2000
An entirely humanized CD3 zeta-chain signaling receptor that directs peripheral blood t cells to specific lysis of carcinoembryonic antigen-positive tumor cells
A Hombach, C Schneider, D Sent, et al.
Der Pathologe
|
August 24, 2010
[Adoptive T-cell therapy of rhabdomyosarcoma]
K Simon-Keller, A Paschen, S Eichmüller, et al.
Page
of 7